Wuzhou Drug International Trading Co., Ltd., (hereinafter called “WUZHOU”) submitted Trogarzo Biological License Application (BLA) to the Hong Kong and Macau Drug Administration Agencies.
The review period for BLA in Hong Kong is expected to be approximately 10 months; In Macau, the review period is about 4 months.
Trogarzo IV infustion and IV push administrations have been approved by the US-FDA for marketing and sales. It will be gradually extended to other countries and regions.